ClinicalTrials.Veeva

Menu

Assessment of Serum Levels of Adenosine Deaminase and Immunoglobulin E in Patients With Chronic Spontaneous Urticaria

S

Sohag University

Status

Not yet enrolling

Conditions

Chronic Spontaneous Urticaria

Treatments

Diagnostic Test: Adenosine deaminase serum level
Diagnostic Test: IgE antibodies serum level

Study type

Observational

Funder types

Other

Identifiers

NCT05992987
Soh-Med-23-07-12MS

Details and patient eligibility

About

adenosine deaminase activity (ADA) has been reported to be elevated in various diseases such as psoriasis, acne and juvenile idiopathic arthritis. There is no previous studies that assessed ADA in chronic spontaneous urticaria (CSU) .

Enrollment

90 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adult patients complaining of CSU and a group of age and sex-matched healthy controls (blood donors).

Exclusion criteria

  • Pregnancy and lactation.
  • Patients with systemic diseases, especially those with autoimmune diseases and infections.
  • Patients with skin diseases.
  • Patients on medications such as antibiotics, nonsteroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors, anticonvulsants, penicillin, and combined oral contraceptives.

Trial design

90 participants in 2 patient groups

CSU group
Description:
Adult patients complaining of chronic spontaneous urticaria (CSU)
Treatment:
Diagnostic Test: Adenosine deaminase serum level
Diagnostic Test: IgE antibodies serum level
Control group
Description:
A group of age and sex-matched healthy controls (blood donors).
Treatment:
Diagnostic Test: Adenosine deaminase serum level
Diagnostic Test: IgE antibodies serum level

Trial contacts and locations

0

Loading...

Central trial contact

Ahmed M Ahmed, M.B.B.Ch; Ramadan Saleh, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems